Polen Michael R, Freeborn Donald K, Lynch Frances L, Mullooly John P, Dickinson Daniel M
Center for Health Research, Kaiser Permanente Northwest, 3800 N. Interstate Avenue, Portland, OR 97227, USA.
J Behav Health Serv Res. 2006 Jul;33(3):335-46. doi: 10.1007/s11414-006-9020-8.
The purpose of this study was to determine whether specialty alcohol and other drug (AOD) treatment is associated with reduced subsequent medical care costs. AOD treatment costs and medical costs in a group model health maintenance organization (HMO) were collected for up to 6 years on 1,472 HMO members who were recommended for specialty AOD treatment, and on 738 members without AOD diagnoses or treatment. Addiction Severity Index measures were also obtained from a sample of 293 of those recommended for treatment. Changes in medical costs did not differ between treatment and comparison groups. Nor did individuals with improved treatment outcomes have greater reductions in medical costs. AOD treatment costs were not inversely related to subsequent medical costs, except for a subgroup with recent AOD treatment. In the interviewed sample, better treatment outcomes did not predict lower subsequent medical costs. Multiple treatment episodes may hold promise for producing cost-offsets.
本研究的目的是确定专科酒精及其他药物（AOD）治疗是否与后续医疗费用的降低相关。在一个团体模式的健康维护组织（HMO）中，收集了1472名被推荐接受专科AOD治疗的HMO成员以及738名无AOD诊断或治疗的成员长达6年的AOD治疗费用和医疗费用。还从293名被推荐治疗的样本中获取了成瘾严重程度指数测量值。治疗组和对照组之间的医疗费用变化没有差异。治疗结果改善的个体在医疗费用降低方面也没有更大幅度的减少。除了近期接受AOD治疗的一个亚组外，AOD治疗费用与后续医疗费用并非呈负相关。在接受访谈的样本中，更好的治疗结果并不能预测更低的后续医疗费用。多次治疗可能有望产生成本抵消。
Zotero 插件